{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:21:48Z","timestamp":1792696908481,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/j.biopha.2024.116594","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC0687"],"award-info":[{"award-number":["2023NSFSC0687"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274187"],"award-info":[{"award-number":["82274187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116594","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T11:01:22Z","timestamp":1713006082000},"page":"116594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["RETRACTED: Molecular insights into experimental models and therapeutics for cholestasis"],"prefix":"10.1016","volume":"174","author":[{"given":"Wenwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiman","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-0369","authenticated-orcid":false,"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116594_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3727\/105221619X15614873062730","article-title":"Inflammation and cell death during cholestasis: the evolving role of bile acids","volume":"19","author":"Woolbright","year":"2019","journal-title":"Gene Expr."},{"key":"10.1016\/j.biopha.2024.116594_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116594_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155573","article-title":"Optimized therapeutic potential of Yinchenhao decoction for cholestatic hepatitis by combined network meta-analysis and network pharmacology","volume":"129","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.116594_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.biopha.2024.116594_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jceh.2021.08.017","article-title":"A current understanding of bile acids in chronic liver disease","volume":"12","author":"Farooqui","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2021.05.012","article-title":"The inhibition of NF\u043aB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity","volume":"349","author":"Ahmadi","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2024.116594_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/liv.14800","article-title":"Rodent models of cholestatic liver disease: A practical guide for translational research","volume":"41","author":"Gijbels","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2024.116594_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jhep.2007.03.012","article-title":"Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis","volume":"47","author":"Honda","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113816","article-title":"Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats","volume":"270","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113658","article-title":"Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on \u03b1-naphthylisothiocyanate (ANIT) -induced cholestasis in rats","volume":"268","author":"Qiu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.chemrestox.9b00148","article-title":"Industrial, biocide, and cosmetic chemical inducers of cholestasis","volume":"32","author":"Vilas-Boas","year":"2019","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.biopha.2024.116594_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF02773758","article-title":"Scanning electron microscopy on the rat liver with alphanaphthylisothiocyanate-induced cholestasis","volume":"15","author":"Yoshino","year":"1980","journal-title":"Gastroenterol. Jpn"},{"key":"10.1016\/j.biopha.2024.116594_bib14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/0006-2952(91)90353-7","article-title":"Involvement of glutathione in 1-naphthylisothiocyanate (ANIT) metabolism and toxicity to isolated hepatocytes","volume":"42","author":"Carpenter-Deyo","year":"1991","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122269","article-title":"Metabolomics research on the hepatoprotective effect of cultured bear bile powder in \u03b1-naphthylisothiocyanate-induced cholestatic mice","volume":"1153","author":"Wu","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.biopha.2024.116594_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.fct.2018.07.022","article-title":"Metabolomic analysis of cholestatic liver damage in mice","volume":"120","author":"Yang","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.116594_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115248","article-title":"Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway","volume":"408","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib18","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/s41467-022-32575-8","article-title":"Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2022.05.044","article-title":"TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation","volume":"77","author":"Labiano","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib20","doi-asserted-by":"crossref","first-page":"G355","DOI":"10.1152\/ajpgi.00458.2005","article-title":"ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18","volume":"291","author":"Kodali","year":"2006","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2024.116594_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopha.2017.02.084","article-title":"Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway","volume":"89","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116594_bib22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116594_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115253","article-title":"Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism","volume":"205","author":"Li","year":"2022","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116594_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biom12010130","article-title":"Lithocholic Acid Amides as Potent Vitamin D Receptor Agonists","volume":"12","author":"Yoshihara","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116594_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3892\/mmr.2020.11210","article-title":"Cholestatic models induced by lithocholic acid and \u03b1-naphthylisothiocyanate: Different etiological mechanisms for liver injury but shared JNK\/STAT3 signaling","volume":"22","author":"Xu","year":"2020","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.24193","article-title":"Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice","volume":"53","author":"Matsubara","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.lfs.2018.12.050","article-title":"Lithocholic acid activates mTOR signaling inducing endoplasmic reticulum stress in placenta during intrahepatic cholestasis of pregnancy","volume":"218","author":"Chao","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116594_bib29","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1039\/D0FO01899F","article-title":"Velvet antler polypeptide prevents the disruption of hepatic tight junctions via inhibiting oxidative stress in cholestatic mice and liver cell lines","volume":"11","author":"Li","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2024.116594_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.gastro.2018.04.032","article-title":"Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer","volume":"155","author":"Liu","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116594_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-4274(92)90061-N","article-title":"Potentiation of lithocholic-acid-induced cholestasis by methyl isobutyl ketone","volume":"61","author":"Joseph","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2024.116594_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113544","article-title":"Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis","volume":"267","author":"Zou","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib33","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.3390\/nu14194090","article-title":"Protective Effect of Rhus chinensis Mill. Fruits on 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-Induced Cholestasis in Mice via Ameliorating Oxidative Stress and Inflammation","volume":"14","author":"Sun","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116594_bib34","first-page":"249","author":"Pose","year":"2019","journal-title":"3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model Cholestasis Res."},{"key":"10.1016\/j.biopha.2024.116594_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","article-title":"A New Xenobiotic-Induced Mouse Model of Sclerosing Cholangitis and Biliary Fibrosis","volume":"171","author":"Fickert","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ajpath.2020.03.010","article-title":"Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model","volume":"190","author":"Zhou","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113706","article-title":"Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters","volume":"269","author":"Xue","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib38","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.28774","article-title":"Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice","volume":"64","author":"Okabe","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.761255","article-title":"The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives","volume":"12","author":"Zu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/hep.28564","article-title":"Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis","volume":"64","author":"Marrone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2016.05.056","article-title":"Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17\u03b1-ethynylestradiol-induced cholestasis: Involvement of PI3K\/Akt signaling pathway","volume":"190","author":"Wu","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0016-5085(00)70425-2","article-title":"Expression of the bile salt export pump is maintained after chronic cholestasis in the rat","volume":"118","author":"Lee","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116594_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejps.2018.08.005","article-title":"The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17\u03b1-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats","volume":"123","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116594_bib44","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1039\/C9FO00318E","article-title":"Hepatoprotection of auraptene from the peels of citrus fruits against 17\u03b1-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2024.116594_bib45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/00498254.2013.783250","article-title":"Effects of 17\u03b1-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin","volume":"43","author":"Choi","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2024.116594_bib46","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101844RR","article-title":"Gestational cholestasis induced intrauterine growth restriction through triggering IRE1\u03b1-mediated apoptosis of placental trophoblast cells","volume":"36","author":"Gao","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2024.116594_bib47","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.biopha.2019.01.020","article-title":"Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line","volume":"111","author":"Morgan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116594_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.livres.2019.01.004","article-title":"Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation","volume":"3","author":"Li","year":"2019","journal-title":"Liver Res."},{"key":"10.1016\/j.biopha.2024.116594_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14740338.2.3.287","article-title":"Drug-induced cholestasis","volume":"2","author":"Velayudham","year":"2003","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2024.116594_bib50","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00204-022-03321-2","article-title":"Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis","volume":"96","author":"Karsten","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2024.116594_bib51","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hep.1840130204","article-title":"Cholestasis and changes of portal pressure caused by chlorpromazine in the perfused rat liver","volume":"13","author":"Akerboom","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib52","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Anth\u00e9rieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1004844","article-title":"Involvement of oxidative species in cyclosporine-mediated cholestasis","volume":"13","author":"Nsengimana","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib54","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.12688\/f1000research.26632.1","article-title":"Glibenclamide, ATP and metformin increases the expression of human bile salt export pump ABCB11","volume":"9","author":"Vats","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.biopha.2024.116594_bib55","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid\u2013induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib56","first-page":"195","article-title":"Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1\u03b1, J Hepatobiliary Pancreat Sci","volume":"25","author":"Zhu","year":"2018"},{"key":"10.1016\/j.biopha.2024.116594_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2021.04.019","article-title":"Paricalcitol inhibits oxidative stress-induced cell senescence of the bile duct epithelium dependent on modulating Sirt1 pathway in cholestatic mice","volume":"169","author":"Jia","year":"2021","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116594_bib58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3892\/ijmm.2017.2922","article-title":"Apamin suppresses biliary fibrosis and activation of hepatic stellate cells","volume":"39","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2024.116594_bib59","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3748\/wjg.v27.i17.1973","article-title":"S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis","volume":"27","author":"Dong","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1159\/000527142","article-title":"Effects of Bile Duct Ligation and Ghrelin Treatment on the Colonic Barrier and Microbiome of Mice","volume":"107","author":"Ehlers","year":"2022","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2024.116594_bib61","doi-asserted-by":"crossref","DOI":"10.3791\/52438-v","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","author":"Tag","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2024.116594_bib62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.32101","article-title":"Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition\u2013associated cholestasis in mice","volume":"75","author":"El Kasmi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib63","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/s41467-018-03764-1","article-title":"Macrophage-derived IL-1\u03b2\/NF-\u03baB signaling mediates parenteral nutrition-associated cholestasis","volume":"9","author":"El Kasmi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90510-1","article-title":"Human induced pluripotent stem cell derived hepatocytes provide insights on parenteral nutrition associated cholestasis in the immature liver","volume":"11","author":"Nghiem-Rao","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib65","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MPG.0000000000002617","article-title":"Gram-negative Microbiota Blooms in Premature Twins Discordant for Parenteral Nutrition-associated Cholestasis","volume":"70","author":"Hourigan","year":"2020","journal-title":"J. Pedia Gastroenterol. Nutr."},{"key":"10.1016\/j.biopha.2024.116594_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.21037\/tp-21-503","article-title":"Etiology of neonatal cholestasis after emerging molecular diagnostics","volume":"11","author":"Wang","year":"2022","journal-title":"Transl. Pedia"},{"key":"10.1016\/j.biopha.2024.116594_bib67","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/cells9091949","article-title":"IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice","volume":"9","author":"Hahn","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116594_bib68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.30513","article-title":"Deficiency of Both Farnesoid X Receptor and Takeda G Protein\u2013Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice","volume":"70","author":"Ferrell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep4.1274","article-title":"Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis","volume":"3","author":"Kim","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2018.09.010","article-title":"Gut microbiota translocation promotes autoimmune cholangitis","volume":"95","author":"Ma","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2024.116594_bib71","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/hmg\/ddaa197","article-title":"Loss of Anks6 leads to YAP deficiency and liver abnormalities","volume":"29","author":"Airik","year":"2020","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2024.116594_bib72","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41374-018-0101-0","article-title":"Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2\u2212\/\u2212 mice and human primary sclerosing cholangitis","volume":"98","author":"Meng","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.biopha.2024.116594_bib73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41385-020-00347-6","article-title":"Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis","volume":"14","author":"Gao","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.116594_bib74","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.30927","article-title":"Wnt\/\u03b2-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease","volume":"71","author":"Pradhan-Sundd","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib75","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.ajpath.2020.07.007","article-title":"Knockout of the tachykinin receptor 1 in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse model of primary sclerosing cholangitis reduces biliary damage and liver fibrosis","volume":"190","author":"Ceci","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib76","first-page":"2263","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis, Hepatology","volume":"59","author":"Tabibian","year":"2014"},{"key":"10.1016\/j.biopha.2024.116594_bib77","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41374-018-0093-9","article-title":"Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2\u2212\/\u2212 mice by diminishing senescence of cholangiocytes","volume":"98","author":"Zhou","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.biopha.2024.116594_bib78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.29464","article-title":"Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-\/-) mice","volume":"67","author":"Moncsek","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib79","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct\u2013ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116594_bib80","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1197847","article-title":"Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice","volume":"14","author":"Wei","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib82","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann","year":"2018","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116594_bib83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI42846","article-title":"Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis","volume":"121","author":"Anakk","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.116594_bib84","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/en.2018-00110","article-title":"Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis","volume":"159","author":"Kim","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2024.116594_bib85","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.7150\/thno.28676","article-title":"Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116594_bib86","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ajpath.2019.11.012","article-title":"Toll-Like receptor 5 signaling ameliorates liver fibrosis by inducing interferon \u03b2\u2013modulated il-1 receptor antagonist in mice","volume":"190","author":"Zhou","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib87","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2013.08.047","article-title":"Toll-Like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System","volume":"145","author":"Brun","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116594_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.31029","article-title":"The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice","volume":"142","author":"Song","year":"2018","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2024.116594_bib89","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101387R","article-title":"Mitigation of portal fibrosis and cholestatic liver disease in ANKS6 -deficient livers by macrophage depletion","volume":"36","author":"Airik","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2024.116594_bib90","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1038\/ncomms7023","article-title":"ANKS6 is the critical activator of NEK8 kinase in embryonic situs determination and organ patterning","volume":"6","author":"Czarnecki","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136781","article-title":"ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice","volume":"10","author":"Delestr\u00e9","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116594_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1093526619881541","article-title":"Clinical and Pathological Features of a Newborn With Compound Heterozygous ANKS6 Variants","volume":"23","author":"Kulkarni","year":"2020","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib93","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","article-title":"Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease","volume":"159","author":"Ramli","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116594_bib94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116594_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4360","article-title":"Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids","volume":"23","author":"Sampaziotis","year":"2017","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.116594_bib96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.31252","article-title":"Regional Differences in Human Biliary Tissues and Corresponding In Vitro\u2013Derived Organoids","volume":"73","author":"Rimland","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3275","article-title":"Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation","volume":"33","author":"Sampaziotis","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116594_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79082-8","article-title":"Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease","volume":"10","author":"Verstegen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib99","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.bbadis.2017.07.037","article-title":"Repopulating the biliary tree from the peribiliary glands","volume":"1864","author":"de Jong","year":"2018","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116594_bib100","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116594_bib101","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2024.116594_bib103","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib106","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.116594_bib107","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","article-title":"Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism","volume":"75","author":"Li","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib108","article-title":"Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice","volume":"4","author":"Kunst","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib109","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib110","first-page":"299","author":"Keitel","year":"2019","journal-title":"Target. FXR Cholestasis"},{"key":"10.1016\/j.biopha.2024.116594_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115854","article-title":"Calculus Bovis Sativus alleviates estrogen cholestasis-induced gut and liver injury in rats by regulating inflammation, oxidative stress, apoptosis, and bile acid profiles","volume":"302","author":"Xiang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib113","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.biopha.2024.116594_bib114","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/hep.32028","article-title":"Mast cells regulate ductular reaction and intestinal inflammation in cholestasis through farnesoid X receptor signaling","volume":"74","author":"Meadows","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib115","article-title":"Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2 mouse","volume":"3","author":"Alsuraih","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib116","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bph.14886","article-title":"Rosiglitazone alleviates intrahepatic cholestasis induced by \u03b1-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-\u039412,14 -PGJ2 and Nogo","volume":"177","author":"Zhang","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117089","article-title":"Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation","volume":"319","author":"Gao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib118","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and apoptotic body: disease message and therapeutic target potentials","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib119","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.116594_bib120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, Pyroptosis, and Necroptosis\u2014Oh My! The Many Ways a Cell Can Die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116594_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2015.01.009","article-title":"Bile acid signaling and biliary functions","volume":"5","author":"Jones","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.116594_bib123","doi-asserted-by":"crossref","first-page":"G498","DOI":"10.1152\/ajpgi.00482.2007","article-title":"CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury","volume":"294","author":"Tamaki","year":"2008","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2024.116594_bib124","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41401-023-01081-y","article-title":"TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP\/PKA\/c-FLIP\/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis","volume":"44","author":"Yang","year":"2023","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.116594_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3716609","article-title":"Activation of TGR5 Ameliorates streptozotocin-induced cognitive impairment by modulating apoptosis, neurogenesis, and neuronal firing","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2024.116594_bib126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2022.01.039","article-title":"Neuroprotective effect of exosomes derived from bone marrow mesenchymal stem cells via activating TGR5 and suppressing apoptosis","volume":"593","author":"Liu","year":"2022","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib127","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116594_bib128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116594_bib129","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1111\/febs.16336","article-title":"Nrf2 and oxidative stress in liver ischemia\/reperfusion injury","volume":"289","author":"G. Bardallo","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2024.116594_bib130","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib131","first-page":"117","author":"Heidari","year":"2019","journal-title":"Role Study Mitochondrial Impair. Oxid. Stress Cholestasis"},{"key":"10.1016\/j.biopha.2024.116594_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2017.11.012","article-title":"Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis\/Inflammatory Bowel Disease","volume":"104","author":"Shearn","year":"2018","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2024.116594_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102452","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"56","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116594_bib134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jhep.2022.01.020","article-title":"Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity","volume":"77","author":"Ghallab","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00116","article-title":"Dioscin Protects ANIT-Induced intrahepatic cholestasis through regulating transporters, apoptosis and oxidative stress","volume":"8","author":"Yao","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib136","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ptr.5431","article-title":"Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K\/Akt-dependent pathway in rats","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2024.116594_bib137","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/nu12061576","article-title":"Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma","volume":"12","author":"Uchida","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116594_bib138","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","article-title":"Chronic liver disease and oxidative stress \u2013 a narrative review","volume":"15","author":"Seen","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib139","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","article-title":"Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents","volume":"81","author":"Hasegawa","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2024.116594_bib140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib141","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.14309\/ajg.0000000000000268","article-title":"Primary Biliary Cholangitis and Primary Sclerosing Cholangitis","volume":"114","author":"Yokoda","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01084","article-title":"Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery","volume":"11","author":"Wei","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib143","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2174\/1389200219666180427165035","article-title":"Drug-induced Cholestasis: Mechanisms, Models, and Markers","volume":"19","author":"Chatterjee","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2024.116594_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081846","article-title":"Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury","volume":"10","author":"Petrescu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116594_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153378","article-title":"Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor","volume":"80","author":"Wei","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.116594_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.biopha.2024.116594_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107867","article-title":"The pathophysiological function of non-gastrointestinal farnesoid X receptor","volume":"226","author":"Yan","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.116594_bib148","first-page":"1191","article-title":"Bile acid metabolism and signaling","author":"Chiang","year":"2013","journal-title":"Compr. Physiol. 3"},{"key":"10.1016\/j.biopha.2024.116594_bib149","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.116594_bib150","article-title":"BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination","volume":"6","author":"Jung","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2024.116594_bib151","doi-asserted-by":"crossref","first-page":"G618","DOI":"10.1152\/ajpgi.00363.2015","article-title":"Nuclear factor-\u03baB regulates the expression of multiple genes encoding liver transport proteins","volume":"310","author":"Balasubramaniyan","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2024.116594_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.729828","article-title":"Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders","volume":"12","author":"Appelman","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.116594_bib153","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2024.116594_bib154","article-title":"SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116594_bib155","article-title":"Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.31265","article-title":"FXR Agonists as Therapy for Liver Disease","volume":"72","author":"Hoofnagle","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib157","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib158","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jcp.25921","article-title":"All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression","volume":"233","author":"Shimizu","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2024.116594_bib159","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/liv.13698","article-title":"Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents","volume":"38","author":"Yu","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.biopha.2024.116594_bib160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/jpet.113.209353","article-title":"All-trans-retinoic acid improves cholestasis in \u03b1-naphthylisothiocyanate-treated rats and Mdr2-\/- mice","volume":"349","author":"Cai","year":"2014","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.116594_bib161","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/MCG.0000000000000591","article-title":"Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study","volume":"51","author":"Assis","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107791","article-title":"Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis","volume":"222","author":"Han","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.116594_bib163","article-title":"PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116594_bib164","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/biom13081264","article-title":"Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease","volume":"13","author":"Kamata","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116594_bib165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jhbp.281","article-title":"Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis","volume":"22","author":"Mizuno","year":"2015","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.biopha.2024.116594_bib166","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinre.2018.06.009","article-title":"Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience","volume":"42","author":"Lemoinne","year":"2018","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116594_bib167","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/jcmm.15028","article-title":"Therapeutic potential of PPAR\u03b3 natural agonists in liver diseases","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116594_bib168","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2147\/DDDT.S310163","article-title":"The Agonists of Peroxisome Proliferator-Activated Receptor-\u03b3 for Liver Fibrosis","volume":"15","author":"Li","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2024.116594_bib169","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbadis.2018.11.004","article-title":"Troglitazone activates TRPV1 and causes deacetylation of PPAR\u03b3 in 3T3-L1 cells","volume":"1865","author":"Krishnan","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116594_bib170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.biopha.2024.116594_bib171","article-title":"Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.biopha.2024.116594_bib172","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/164_2019_235","article-title":"The Enterokine Fibroblast Growth Factor 15\/19 in Bile Acid Metabolism","author":"Cariello","year":"2019","journal-title":"Handb. Exp. Pharm. 256"},{"key":"10.1016\/j.biopha.2024.116594_bib173","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib174","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jhep.2018.11.032","article-title":"Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis","volume":"70","author":"Rinella","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116594_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718841","article-title":"Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis","volume":"12","author":"Reuveni","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116594_bib176","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hep.24044","article-title":"B cell depletion therapy exacerbates murine primary biliary cirrhosis","volume":"53","author":"Dhirapong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116594_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02534","article-title":"Anti-drug antibodies against a novel humanized anti-CD20 antibody impair its therapeutic effect on primary biliary cholangitis in human CD20- and Fc\u03b3R-expressing mice","volume":"9","author":"Moritoki","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116594_bib178","doi-asserted-by":"crossref","first-page":"28588","DOI":"10.18632\/oncotarget.5665","article-title":"CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b\u2212\/\u2212 mice favoring autoimmune cholangitis","volume":"6","author":"Concepcion","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116594_bib179","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s11596-021-2458-3","article-title":"Cyr61 Alleviates Cholangitis by Inhibiting Cytotoxic Effects of CD8+ T Cells on Biliary Epithelial Cells","volume":"41","author":"Cheng","year":"2021","journal-title":"Curr. Med Sci."},{"key":"10.1016\/j.biopha.2024.116594_bib180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12906-015-0637-0","article-title":"Large dose means significant effect \u2013 dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats","volume":"15","author":"Zhao","year":"2015","journal-title":"BMC Complement Alter. Med"},{"key":"10.1016\/j.biopha.2024.116594_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00014","article-title":"Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall","volume":"7","author":"Ma","year":"2016","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib182","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.2147\/DDDT.S90030","article-title":"Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K\/Akt signaling pathway","author":"Zhao","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2024.116594_bib183","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jphp.13008","article-title":"Paeonia lactiflora Pall. regulates the NF-\u03baB-NLRP3 inflammasome pathway to alleviate cholestasis in rats","volume":"70","author":"Ma","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116594_bib184","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/13880209.2018.1517185","article-title":"Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury","volume":"56","author":"Zhang","year":"2018","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2024.116594_bib185","article-title":"Paeoniflorin alleviates 17\u03b1-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib186","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/abbs\/gmu010","article-title":"Paeoniflorin protects cells from GalN\/TNF-\u03b1-induced apoptosis via ER stress and mitochondria-dependent pathways in human L02 hepatocytes","volume":"46","author":"Jiang","year":"2014","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.biopha.2024.116594_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175331","article-title":"Validation of MAPK signalling pathway as a key role of paeoniflorin in the treatment of intrahepatic cholestasis of pregnancy based on network pharmacology and metabolomics","volume":"935","author":"Wang","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib188","first-page":"1","article-title":"Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway","volume":"2021","author":"Chen","year":"2021","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2024.116594_bib189","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopha.2017.02.025","article-title":"Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats","volume":"89","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116594_bib190","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fct.2013.04.030","article-title":"Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats","volume":"58","author":"Zhao","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.116594_bib191","article-title":"Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury","volume":"3","author":"Iruzubieta","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2024.116594_bib192","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.livres.2020.10.003","article-title":"Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function","volume":"5","author":"Ommati","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.biopha.2024.116594_bib193","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.livres.2020.12.001","article-title":"Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function","volume":"5","author":"Ommati","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.biopha.2024.116594_bib194","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2478\/s11756-020-00576-x","article-title":"Betaine alleviates cholestasis-associated renal injury by mitigating oxidative stress and enhancing mitochondrial function","volume":"76","author":"Ommati","year":"2021","journal-title":"Biol. (Bratisl. )"},{"key":"10.1016\/j.biopha.2024.116594_bib195","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/toxres\/tfab073","article-title":"The activation of nuclear factor-E2-related factor 2 (Nrf2)\/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury","volume":"10","author":"Mousavi","year":"2021","journal-title":"Toxicol. Res (Camb. )"},{"key":"10.1016\/j.biopha.2024.116594_bib196","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22846","article-title":"Disturbed mitochondrial redox state and tissue energy charge in cholestasis","volume":"35","author":"Ghanbarinejad","year":"2021","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.biopha.2024.116594_bib197","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.toxlet.2020.05.012","article-title":"Poly (ADP-Ribose) polymerase-1 (PARP-1) overactivity plays a pathogenic role in bile acids-induced nephrotoxicity in cholestatic rats","volume":"330","author":"Siavashpour","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2024.116594_bib198","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00210-020-02041-7","article-title":"Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis","volume":"394","author":"Ghanbarinejad","year":"2021","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2024.116594_bib199","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000530307","article-title":"Cholestasis-Associated pulmonary inflammation, oxidative stress, and tissue fibrosis: the protective role of the biogenic amine agmatine","volume":"108","author":"Ommati","year":"2023","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2024.116594_bib200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.toxlet.2019.09.009","article-title":"Cholestasis-associated reproductive toxicity in male and female rats: The fundamental role of mitochondrial impairment and oxidative stress","volume":"316","author":"Ommati","year":"2019","journal-title":"Toxicol. Lett."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2024.116594","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}},{"DOI":"10.1016\/j.biopha.2026.119693","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000}},{"DOI":"10.1016\/j.biopha.2026.119693","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"record-id":"71623"},{"DOI":"10.1016\/j.biopha.2026.119693","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:32:06Z","timestamp":1785094326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":200,"alternative-id":["S0753332224004785"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116594","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Molecular insights into experimental models and therapeutics for cholestasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116594"}}